Alkermes plc Price/Book
What is the Price/Book of Alkermes plc?
The Price/Book of Alkermes plc is 3.37
What is the definition of Price/Book?
Price to book ratio represents the ratio between a company’s stock value and the book value per share.
mrq (most recent quarter)
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Price/Book of companies in the Health Care sector on NASDAQ compared to Alkermes plc
What does Alkermes plc do?
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Companies with price/book similar to Alkermes plc
- NuZee has Price/Book of 3.37
- Nova Ltd has Price/Book of 3.37
- Eaton plc has Price/Book of 3.37
- Garden Reach Shipbuilders & Engineers has Price/Book of 3.37
- Virbac SA has Price/Book of 3.37
- Infinity Logistics and Transport Ventures has Price/Book of 3.37
- Alkermes plc has Price/Book of 3.37
- CreditAccess Grameen has Price/Book of 3.37
- Electrosteel Castings has Price/Book of 3.37
- Q2 Inc has Price/Book of 3.37
- SNP Schneider-Neureither & Partner SE has Price/Book of 3.38
- Think Childcare has Price/Book of 3.38
- Comfort Systems USA has Price/Book of 3.38